These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34550529)

  • 1. ImmunoPET: harnessing antibodies for imaging immune cells.
    Wu AM; Pandit-Taskar N
    Mol Imaging Biol; 2022 Apr; 24(2):181-197. PubMed ID: 34550529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-64-immunoPET imaging: bench to bedside.
    Natarajan A
    Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):356-363. PubMed ID: 33045821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology.
    Knowles SM; Wu AM
    J Clin Oncol; 2012 Nov; 30(31):3884-92. PubMed ID: 22987087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124.
    Kumar K; Ghosh A
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33466827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of immunoPET in receptor targeted cancer therapy.
    Marik J; Junutula JR
    Curr Drug Deliv; 2011 Jan; 8(1):70-8. PubMed ID: 21034420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ImmunoPET in oncology.
    Mulero F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(5):332-339. PubMed ID: 35961857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ImmunoPET imaging of human CD8
    Zhao H; Wang C; Yang Y; Sun Y; Wei W; Wang C; Wan L; Zhu C; Li L; Huang G; Liu J
    J Nanobiotechnology; 2021 Feb; 19(1):42. PubMed ID: 33563286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective.
    Wang Q; Zhang X; Wei W; Cao M
    Mol Pharm; 2022 Oct; 19(10):3471-3483. PubMed ID: 35771950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive progress in immunoPET--not just a coincidence.
    McCabe KE; Wu AM
    Cancer Biother Radiopharm; 2010 Jun; 25(3):253-61. PubMed ID: 20578830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ImmunoPET: Concept, Design, and Applications.
    Wei W; Rosenkrans ZT; Liu J; Huang G; Luo QY; Cai W
    Chem Rev; 2020 Apr; 120(8):3787-3851. PubMed ID: 32202104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered antibodies for molecular imaging of cancer.
    Wu AM
    Methods; 2014 Jan; 65(1):139-47. PubMed ID: 24091005
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    McKnight BN; Viola-Villegas NT
    J Labelled Comp Radiopharm; 2018 Jul; 61(9):727-738. PubMed ID: 29341222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome Prediction and Evaluation by Imaging the Key Elements of Therapeutic Responses to Cancer Immunotherapies Using PET.
    Bu L; Sun Y; Han G; Tu N; Xiao J; Wang Q
    Curr Pharm Des; 2020; 26(6):675-687. PubMed ID: 31465273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience.
    de Lucas ÁG; Lamminmäki U; López-Picón FR
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current state and upcoming opportunities for immunoPET biomarkers in lung cancer.
    Slebe M; Pouw JEE; Hashemi SMS; Menke-van der Houven van Oordt CW; Yaqub MM; Bahce I
    Lung Cancer; 2022 Jul; 169():84-93. PubMed ID: 35679715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
    Tavaré R; Escuin-Ordinas H; Mok S; McCracken MN; Zettlitz KA; Salazar FB; Witte ON; Ribas A; Wu AM
    Cancer Res; 2016 Jan; 76(1):73-82. PubMed ID: 26573799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies for molecular imaging of cancer.
    Wu AM; Olafsen T
    Cancer J; 2008; 14(3):191-7. PubMed ID: 18536559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ImmunoPET imaging of hematological malignancies: From preclinical promise to clinical reality.
    Dun Y; Huang G; Liu J; Wei W
    Drug Discov Today; 2022 Apr; 27(4):1196-1203. PubMed ID: 34838729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8
    Seo JW; Tavaré R; Mahakian LM; Silvestrini MT; Tam S; Ingham ES; Salazar FB; Borowsky AD; Wu AM; Ferrara KW
    Clin Cancer Res; 2018 Oct; 24(20):4976-4987. PubMed ID: 29967252
    [No Abstract]   [Full Text] [Related]  

  • 20. [
    Gallegos CA; Lu Y; Clements JC; Song PN; Lynch SE; Mascioni A; Jia F; Hartman YE; Massicano AVF; Houson HA; Lapi SE; Warram JM; Markert JM; Sorace AG
    Theranostics; 2024; 14(3):911-923. PubMed ID: 38250045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.